HPV 9-in-1 Vaccine
Human Papillomavirus comprises a cluster of more than 150 distinct genotypes, with nearly 40 affecting human genital organs and producing various diseases or indications. Any sexually active individual has the potential to contract HPV. Although it may not initially show any symptoms, one’s immune system can clear up a mild form of HPV infection early on.
HPV is composed of various genotypes, among them are HPV 6, 11, 16, 18, 31, 33, 45, 52 and 58. These can be categorized into low-risk or high-risk types:
Low-risk HPV
High-risk HPV
HPV types 6 and 11 are among those that can lead to the development of genital warts.
Persistent infection has the potential to induce cellular abnormalities that can advance into cancer, notably strains of HPV such as 16, 18, 31, 33, 45, 52 and 58.
What are the modes of transmission for HPV?
HPV transmission can occur through sexual contact, although non-sexual exposure is possible but relatively rare.
Receive Vaccination, Prevent HPV and the Associated Complications
HPV vaccine, commonly referred to as the cervical cancer vaccine, is available in two varieties: 4-in-1 and 9-in-1. The former can shield against four different strains of HPV while the latter can provide protection against nine different strains that include HPV types such as 6, 11, 16, 18, 31, 33, 45, 52 and 58.
Which illnesses can be prevented with HPV vaccination?
HPV vaccine assists in the prevention of the following illnesses:
- Genital warts
- Cervical cancer
- Vulvar cancer
- Vaginal cancer
- Anal cancer
Which individuals are eligible to receive HPV vaccination?
Individuals aged 9 and over, regardless of gender, are eligible to receive HPV immunization. According to the age group, there should be two doses delivered for those aged between 9-14 or three doses administered for ages above 15 years old.
The optimal time frame to receive the HPV vaccine is before an individual becomes sexually active; nevertheless, it may still aid in preventing infection after exposure to the virus.
What are the potential adverse reactions of the HPV vaccine?
The adverse effects of the HPV vaccine are comparable to those of other vaccines, such as soreness and inflammation at the injection site, fever, headache, and nausea. These symptoms generally dissipate after 2 to 3 days. In case these side effects persist or unusual symptoms arise, it is advisable to seek prompt medical attention.
Humansa provides HPV 9-in-1 vaccination packages
FAQs of HPV vaccine
The recommended schedule for receiving doses of the vaccine is different depending on the age group. Individuals between 9 and 14 years old should receive two doses of the vaccine, with a six-month interval period between them, i.e. 0-6 months.
Adults and individuals aged above 15 should have three doses, administered at intervals of 0-6-12 months.
Receiving the HPV vaccine can lower the chance of contracting further strains of HPV, even if you have already been exposed to certain types. This can lower the probability of being infected with other genotypes and decrease the likelihood of developing severe ailments such as cervical cancer, vaginal cancer, or anal cancer.
The above information is for reference only and shall not be considered as medical advice. Please consult with your doctor or healthcare provider for further enquiries.